CFO of Chelsea Therapeutics International Ltd. (CHTP, Financial) J Nick Riehle buys 3,000 shares of CHTP on 11/04/2010 at an average price of $4.83 a share.
Chelsea Therapeutics International Ltd. has a market cap of $199 million; its shares were traded at around $4.91 .
CHTP is in the portfolios of Jim Simons of Renaissance Technologies LLC.
Chelsea Therapeutics International Ltd. has a market cap of $199 million; its shares were traded at around $4.91 .
CHTP is in the portfolios of Jim Simons of Renaissance Technologies LLC.
CEO Recent Trades:
- Buy: CEO Simon Pedder bought 1,250 shares of CHTP stock on 09/02/2010 at the average price of 4.08. Simon Pedder owns at least 488,180 shares after this. The price of the stock has increased by 20.34% since.
Directors and Officers Recent Trades:
- Buy: Vice President of Operations Joseph Oliveto bought 3,500 shares of CHTP stock on 08/12/2010 at the average price of 2.87. Joseph Oliveto owns at least 3,500 shares after this. The price of the stock has increased by 71.08% since.
- Buy: VP, Business Development Michael J Roberts bought 2,000 shares of CHTP stock on 08/11/2010 at the average price of 3.1. Michael J Roberts owns at least 22,000 shares after this. The price of the stock has increased by 58.39% since.
- Buy: 10% Owner Josiah T Austin bought 100,000 shares of CHTP stock on 06/09/2010 at the average price of 2.97. Josiah T Austin owns at least 8,190,487 shares after this. The price of the stock has increased by 65.32% since.
- Buy: Director William Dodge Rueckert bought 15,000 shares of CHTP stock on 06/08/2010 at the average price of 3. William Dodge Rueckert owns at least 40,000 shares after this. The price of the stock has increased by 63.67% since.
- Buy: 10% Owner Josiah T Austin bought 10,000 shares of CHTP stock on 06/04/2010 at the average price of 3.19. Josiah T Austin owns at least 8,090,487 shares after this. The price of the stock has increased by 53.92% since.
